| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving and Sustaining Universal Health Coverage: Fiscal Reform of the National Health Insurance in Taiwan
|
Lan, Jesse Yu-Chen
|
|
2016
|
|
6 |
p. 717-731
|
artikel
|
| 2 |
Acknowledgement
|
|
|
2010
|
|
6 |
p. 355-356
|
artikel
|
| 3 |
Acknowledgement
|
|
|
2012
|
|
6 |
p. 359-360
|
artikel
|
| 4 |
Acknowledgement
|
|
|
2012
|
|
6 |
p. 359-360
|
artikel
|
| 5 |
Acknowledgement
|
|
|
2011
|
|
6 |
p. 349-350
|
artikel
|
| 6 |
Acknowledgement to Referees
|
|
|
2013
|
|
6 |
p. 559-560
|
artikel
|
| 7 |
Acknowledgement to Referees
|
|
|
2016
|
|
6 |
p. 619-621
|
artikel
|
| 8 |
Acknowledgement to Referees
|
|
|
2014
|
|
6 |
p. 569-571
|
artikel
|
| 9 |
Acknowledgement to Referees
|
|
|
2017
|
|
6 |
p. 693-695
|
artikel
|
| 10 |
Acknowledgement to Referees
|
|
|
2015
|
|
6 |
p. 553-555
|
artikel
|
| 11 |
Acknowledgement to Referees
|
|
|
2018
|
|
6 |
p. 745-747
|
artikel
|
| 12 |
Acknowledgement to Referees
|
|
|
|
|
6 |
p. 753-755
|
artikel
|
| 13 |
A Cost-Benefit Analysis of Two Alternative Models of Maternity Care in Ireland
|
Fawsitt, Christopher G.
|
|
2017
|
|
6 |
p. 785-794
|
artikel
|
| 14 |
A Framework to Prioritise Health Research Proposals for Funding: Integrating Value for Money
|
Tuffaha, Haitham W.
|
|
|
|
6 |
p. 761-770
|
artikel
|
| 15 |
A Model-Based Economic Evaluation of Improved Primary Care Management of Patients with Type 2 Diabetes in Australia
|
Haji Ali Afzali, Hossein
|
|
2013
|
|
6 |
p. 661-670
|
artikel
|
| 16 |
An Alternative Approach to Decomposing the Redistributive Effect of Health Financing Between and Within Groups Using the Gini Index: The Case of Out-of-Pocket Payments in Nigeria
|
Ataguba, John E.
|
|
|
|
6 |
p. 747-757
|
artikel
|
| 17 |
Analyzing the Financial Sustainability of User Fee Removal Policies: A Rapid First Assessment Methodology with a Practical Application for Burkina Faso
|
Mathonnat, Jacky
|
|
|
|
6 |
p. 767-780
|
artikel
|
| 18 |
An application of a proposed framework for formulary listing in low-income countries
|
Diaby, Vakaramoko
|
|
2011
|
|
6 |
p. 389-402
|
artikel
|
| 19 |
An Assessment of Domestic Financing for Reproductive, Maternal, Neonatal and Child Health in Sub-Saharan Africa: Potential Gains and Fiscal Space
|
Atim, Chris
|
|
|
|
6 |
p. 789-799
|
artikel
|
| 20 |
An Overview of the Health Economic Implications of Elective Caesarean Section
|
Petrou, Stavros
|
|
2013
|
|
6 |
p. 561-576
|
artikel
|
| 21 |
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines
|
Vandenplas, Yannick
|
|
|
|
6 |
p. 803-817
|
artikel
|
| 22 |
Are the True Impacts of Adverse Events Considered in Economic Models of Antineoplastic Drugs? A Systematic Review
|
Pearce, Alison
|
|
2013
|
|
6 |
p. 619-637
|
artikel
|
| 23 |
A Review of “Cost Effectiveness Modelling for Health Technology Assessment: A Practical Course”
|
Abdulla, Ahmed
|
|
2016
|
|
6 |
p. 733-734
|
artikel
|
| 24 |
A Review of Recent Decision-Analytic Models Used to Evaluate the Economic Value of Cancer Treatments
|
Bullement, Ash
|
|
|
|
6 |
p. 771-780
|
artikel
|
| 25 |
A review of the cost effectiveness of bisphosphonates in the treatment of post-menopausal osteoporosis in Switzerland
|
Lippuner, Kurt
|
|
2011
|
|
6 |
p. 403-417
|
artikel
|
| 26 |
A Review of the Development and Application of Generic Preference-Based Instruments with the Older Population
|
Cleland, Jenny
|
|
|
|
6 |
p. 781-801
|
artikel
|
| 27 |
A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines
|
Thiboonboon, Kittiphong
|
|
2016
|
|
6 |
p. 659-672
|
artikel
|
| 28 |
A Systematic Review of the State of Economic Evaluation for Health Care in India
|
Prinja, Shankar
|
|
2015
|
|
6 |
p. 595-613
|
artikel
|
| 29 |
Authors’ Reply to Gandjour “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review”
|
Laplante, Suzanne
|
|
2016
|
|
6 |
p. 731-732
|
artikel
|
| 30 |
Catastrophic healthcare payments and impoverishment in the occupied Palestinian territory
|
Mataria, Awad
|
|
2010
|
|
6 |
p. 393-405
|
artikel
|
| 31 |
Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?
|
Merlin, Tracy
|
|
|
|
6 |
p. 823-830
|
artikel
|
| 32 |
Child–Parent Agreement in the Assessment of Health-Related Quality of Life Using the CHU9D and the PedsQLTM
|
Khanna, Diana
|
|
|
|
6 |
p. 937-947
|
artikel
|
| 33 |
Comment on: “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review”
|
Gandjour, Afschin
|
|
2016
|
|
6 |
p. 729-730
|
artikel
|
| 34 |
Competitive Health Markets and Risk Equalisation in Australia: Lessons Learnt from Other Countries
|
Fouda, Ayman
|
|
2017
|
|
6 |
p. 745-754
|
artikel
|
| 35 |
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?
|
Thom, Howard
|
|
|
|
6 |
p. 967
|
artikel
|
| 36 |
Correction to: Articles in Themed Issue: Health Financing in Sub-Saharan Africa
|
|
|
|
|
6 |
p. 841-842
|
artikel
|
| 37 |
Correction to: Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta‑analysis
|
Doshmangir, Leila
|
|
|
|
6 |
p. 953
|
artikel
|
| 38 |
Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review
|
Wielage, Ronald C.
|
|
2013
|
|
6 |
p. 593-618
|
artikel
|
| 39 |
Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting
|
Tremblay, Gabriel
|
|
|
|
6 |
p. 827-839
|
artikel
|
| 40 |
Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study
|
Lévesque, Renee
|
|
2015
|
|
6 |
p. 647-659
|
artikel
|
| 41 |
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach
|
Risør, Bettina Wulff
|
|
|
|
6 |
p. 867-880
|
artikel
|
| 42 |
Cost-Effectiveness Analysis of Temocillin Treatment in Patients with Febrile UTI Accounting for the Emergence of Antibiotic Resistance
|
Larsson, Sofie
|
|
|
|
6 |
p. 835-843
|
artikel
|
| 43 |
Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting
|
Muresan, B.
|
|
|
|
6 |
p. 929-940
|
artikel
|
| 44 |
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
|
Michels, Renée Else
|
|
|
|
6 |
p. 857-873
|
artikel
|
| 45 |
Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya
|
Sladkevicius, Erikas
|
|
2010
|
|
6 |
p. 407-420
|
artikel
|
| 46 |
Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden
|
Costa-Scharplatz, Madlaina
|
|
2015
|
|
6 |
p. 637-645
|
artikel
|
| 47 |
Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder
|
Erder, M. Haim
|
|
2012
|
|
6 |
p. 381-395
|
artikel
|
| 48 |
Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder
|
Erder, M. Haim
|
|
2012
|
|
6 |
p. 381-395
|
artikel
|
| 49 |
Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the UK
|
Gladwell, Daniel
|
|
2014
|
|
6 |
p. 611-622
|
artikel
|
| 50 |
Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin
|
Tunis, Sandra L.
|
|
2011
|
|
6 |
p. 351-365
|
artikel
|
| 51 |
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis
|
Clarke, Caroline S.
|
|
|
|
6 |
p. 905-917
|
artikel
|
| 52 |
Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany
|
Hofer, Florian
|
|
2016
|
|
6 |
p. 691-701
|
artikel
|
| 53 |
Cost Utility of Telaprevir–PR (Peginterferon–Ribavirin) Versus Boceprevir–PR and Versus PR Alone in Chronic Hepatitis C in The Netherlands
|
Vellopoulou, Aikaterini
|
|
|
|
6 |
p. 647-659
|
artikel
|
| 54 |
Cost Utility of Telaprevir–PR (Peginterferon–Ribavirin) Versus Boceprevir–PR and Versus PR Alone in Chronic Hepatitis C in The Netherlands
|
Vellopoulou, Aikaterini
|
|
2014
|
|
6 |
p. 647-659
|
artikel
|
| 55 |
COVID-19 Vaccine Demand and Financial Incentives
|
Carpio, Carlos E.
|
|
|
|
6 |
p. 871-883
|
artikel
|
| 56 |
Critique of an economic evaluation using the drummond checklist
|
Doran, Christopher M.
|
|
2010
|
|
6 |
p. 357-359
|
artikel
|
| 57 |
Decision Making and Priority Setting: The Evolving Path Towards Universal Health Coverage
|
Paolucci, Francesco
|
|
2017
|
|
6 |
p. 697-706
|
artikel
|
| 58 |
Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland
|
Fogarty, Emer
|
|
2014
|
|
6 |
p. 635-645
|
artikel
|
| 59 |
Direct Medical Cost and Glycemic Control in Type 2 Diabetic Saudi Patients
|
Almutairi, Nora
|
|
2013
|
|
6 |
p. 671-675
|
artikel
|
| 60 |
Direct Medical Costs of COPD in the USA: An Analysis of the Medical Expenditure Panel Survey 2017–2018
|
Shah, Chintal H.
|
|
|
|
6 |
p. 915-924
|
artikel
|
| 61 |
Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing?
|
Puig-Junoy, Jaume
|
|
2012
|
|
6 |
p. 441-451
|
artikel
|
| 62 |
Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing?
|
Puig-Junoy, Jaume
|
|
2012
|
|
6 |
p. 441-451
|
artikel
|
| 63 |
Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
|
van der Pol, Karel H.
|
|
|
|
6 |
p. 831-840
|
artikel
|
| 64 |
Early retirement and income loss in patients with early and advanced Parkinson’s disease
|
Johnson, Scott
|
|
2011
|
|
6 |
p. 367-376
|
artikel
|
| 65 |
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies
|
Howdon, Daniel
|
|
|
|
6 |
p. 783-792
|
artikel
|
| 66 |
Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges
|
Lamsal, Ramesh
|
|
2017
|
|
6 |
p. 763-772
|
artikel
|
| 67 |
Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands
|
Fragoulakis, Vassilis
|
|
2016
|
|
6 |
p. 719-727
|
artikel
|
| 68 |
Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review
|
Liu, Sibo
|
|
|
|
6 |
p. 841-855
|
artikel
|
| 69 |
Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model
|
Prioli, Katherine M.
|
|
2018
|
|
6 |
p. 889-899
|
artikel
|
| 70 |
Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome
|
Eaddy, Michael
|
|
2012
|
|
6 |
p. 431-440
|
artikel
|
| 71 |
Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome
|
Eaddy, Michael
|
|
2012
|
|
6 |
p. 431-440
|
artikel
|
| 72 |
Effects of the ACA on Preventive Care Disparities
|
Agirdas, Cagdas
|
|
2018
|
|
6 |
p. 859-869
|
artikel
|
| 73 |
EQ-5D-5L Health-State Values for the Mexican Population
|
Gutierrez-Delgado, Cristina
|
|
|
|
6 |
p. 905-914
|
artikel
|
| 74 |
Erratum to: Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany
|
Zeidler, Jan
|
|
2013
|
|
6 |
p. 689
|
artikel
|
| 75 |
Erratum to: Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland
|
Lee, Dawn
|
|
2013
|
|
6 |
p. 687
|
artikel
|
| 76 |
Erratum to: Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis
|
Elliott, Thomas M.
|
|
2017
|
|
6 |
p. 817-818
|
artikel
|
| 77 |
Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis
|
Elliott, Thomas M.
|
|
2017
|
|
6 |
p. 805-816
|
artikel
|
| 78 |
Estimating Catastrophic Health Expenditures from Household Surveys: Evidence from Living Standard Measurement Surveys (LSMS)-Integrated Surveys on Agriculture (ISA) from Sub-Saharan Africa
|
Ssewanyana, Sarah
|
|
|
|
6 |
p. 781-788
|
artikel
|
| 79 |
Estimating the Costs of Torture: Challenges and Opportunities
|
Mpinga, Emmanuel Kabengele
|
|
2015
|
|
6 |
p. 567-581
|
artikel
|
| 80 |
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach
|
Moler-Zapata, Silvia
|
|
|
|
6 |
p. 881-891
|
artikel
|
| 81 |
Estimation of the Direct Cost of Poliomyelitis Rehabilitation Treatment to Pakistani Patients: A 53-Year Retrospective Study
|
Naqvi, Atta Abbas
|
|
2018
|
|
6 |
p. 871-888
|
artikel
|
| 82 |
Evaluating Equity in Health Financing Using Benefit Incidence Analysis: A Framework for Accounting for Quality of Care
|
Asante, Augustine
|
|
|
|
6 |
p. 759-766
|
artikel
|
| 83 |
Evaluating Health Inequality in Five Caribbean Basin Countries Using EQ-5D-5L
|
Bailey, Henry H.
|
|
|
|
6 |
p. 857-866
|
artikel
|
| 84 |
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
|
McManus, Emma
|
|
|
|
6 |
p. 891-903
|
artikel
|
| 85 |
Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population
|
Kirson, Noam Y.
|
|
2011
|
|
6 |
p. 377-387
|
artikel
|
| 86 |
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
|
Padula, William V.
|
|
|
|
6 |
p. 757-759
|
artikel
|
| 87 |
Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries
|
Vogler, Sabine
|
|
|
|
6 |
p. 803-816
|
artikel
|
| 88 |
Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review
|
Pike, Jamison
|
|
2018
|
|
6 |
p. 765-778
|
artikel
|
| 89 |
Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain
|
Dilla, Tatiana
|
|
2012
|
|
6 |
p. 417-430
|
artikel
|
| 90 |
Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain
|
Dilla, Tatiana
|
|
2012
|
|
6 |
p. 417-430
|
artikel
|
| 91 |
Health Expenditure and All-Cause Mortality in the ‘Galaxy’ of Italian Regional Healthcare Systems: A 15-Year Panel Data Analysis
|
Golinelli, Davide
|
|
2017
|
|
6 |
p. 773-783
|
artikel
|
| 92 |
Health Financing in Sub-Saharan Africa: From Analytical Frameworks to Empirical Evaluation
|
Asante, Augustine
|
|
|
|
6 |
p. 743-746
|
artikel
|
| 93 |
Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study
|
Hinde, Sebastian
|
|
|
|
6 |
p. 793-802
|
artikel
|
| 94 |
Health Insurance in Sub-Saharan Africa: A Scoping Review of the Methods Used to Evaluate its Impact
|
Degroote, Stéphanie
|
|
|
|
6 |
p. 825-840
|
artikel
|
| 95 |
Horses for Courses: Moving India towards Universal Health Coverage through Targeted Policy Design
|
Maurya, Dayashankar
|
|
2017
|
|
6 |
p. 733-744
|
artikel
|
| 96 |
Hospital Utilization and Universal Health Insurance Coverage: Evidence from the Massachusetts Health Care Reform Act
|
Cseh, Attila
|
|
2015
|
|
6 |
p. 627-635
|
artikel
|
| 97 |
How a Bottom-Up Multi-Stakeholder Initiative Helped Transform the Renal Replacement Therapy Landscape in Spain
|
Selgas, Rafael
|
|
2017
|
|
6 |
p. 755-762
|
artikel
|
| 98 |
How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13
|
Martin, Stephen
|
|
|
|
6 |
p. 885-903
|
artikel
|
| 99 |
How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
|
Clarke, Caroline S.
|
|
|
|
6 |
p. 797-810
|
artikel
|
| 100 |
Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries
|
Hesse, Ulrik
|
|
2013
|
|
6 |
p. 677-685
|
artikel
|
| 101 |
Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY
|
Brazier, John
|
|
2015
|
|
6 |
p. 557-565
|
artikel
|
| 102 |
Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta-analysis
|
Doshmangir, Leila
|
|
|
|
6 |
p. 839-855
|
artikel
|
| 103 |
Inclusion of Compliance and Persistence in Economic Models
|
Kadambi, Ananth
|
|
2012
|
|
6 |
p. 365-379
|
artikel
|
| 104 |
Inclusion of Compliance and Persistence in Economic Models
|
Kadambi, Ananth
|
|
2012
|
|
6 |
p. 365-379
|
artikel
|
| 105 |
Incremental Cost Effectiveness of Pharmacist-Managed Erythropoiesis-Stimulating Agent Clinics for Non-Dialysis-Dependent Chronic Kidney Disease Patients
|
Aspinall, Sherrie L.
|
|
2013
|
|
6 |
p. 653-660
|
artikel
|
| 106 |
India’s Proposed Universal Health Coverage Policy: Evidence for Age Structure Transition Effect and Fiscal Sustainability
|
Narayana, Muttur Ranganathan
|
|
2016
|
|
6 |
p. 673-690
|
artikel
|
| 107 |
In-Hospital Healthcare Utilization, Outcomes, and Costs in Pre-Hospital-Adjudicated Low-Risk Chest-Pain Patients
|
Dongen, Dominique N. van
|
|
|
|
6 |
p. 875-882
|
artikel
|
| 108 |
Insensitivity to Scope in Contingent Valuation Studies
|
Whitty, Jennifer A.
|
|
2012
|
|
6 |
p. 361-363
|
artikel
|
| 109 |
Insensitivity to Scope in Contingent Valuation Studies
|
Søgaard, Rikke
|
|
2012
|
|
6 |
p. 397-405
|
artikel
|
| 110 |
Insensitivity to Scope in Contingent Valuation Studies
|
Søgaard, Rikke
|
|
2012
|
|
6 |
p. 397-405
|
artikel
|
| 111 |
Insensitivity to Scope in Contingent Valuation Studies
|
Whitty, Jennifer A.
|
|
2012
|
|
6 |
p. 361-363
|
artikel
|
| 112 |
Is Using Sodium-Glucose Cotransporter-2 Inhibitors to Treat Adults with Chronic Heart Failure Cost-Effective? A Systematic Review of Cost-Effectiveness Studies
|
Tan, Yi Jing
|
|
|
|
6 |
p. 857-875
|
artikel
|
| 113 |
Level of Evidence in Economic Evaluations of Left Atrial Appendage Closure Devices: A Systematic Review
|
Nédellec, Etienne
|
|
2018
|
|
6 |
p. 793-802
|
artikel
|
| 114 |
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models
|
Wilson, Edward C. F.
|
|
|
|
6 |
p. 789-795
|
artikel
|
| 115 |
National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India
|
Prinja, Shankar
|
|
|
|
6 |
p. 811-823
|
artikel
|
| 116 |
Parafricta Bootees and Undergarments to Reduce Skin Breakdown in People with or at Risk of Pressure Ulcers: A NICE Medical Technologies Guidance
|
Meads, Catherine
|
|
2016
|
|
6 |
p. 635-646
|
artikel
|
| 117 |
Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry
|
Padula, William V.
|
|
2018
|
|
6 |
p. 753-763
|
artikel
|
| 118 |
Payment Arrangements for Private Healthcare Purchasing Under Publicly Funded Systems in Low- and Middle-Income Countries: Issues and Implications
|
Honda, Ayako
|
|
|
|
6 |
p. 811-823
|
artikel
|
| 119 |
Performance-Based Financing, Basic Packages of Health Services and User-Fee Exemption Mechanisms: An Analysis of Health-Financing Policy Integration in Three Fragile and Conflict-Affected Settings
|
Jacobs, Eelco
|
|
|
|
6 |
p. 801-810
|
artikel
|
| 120 |
Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia
|
Vreman, Rick A.
|
|
|
|
6 |
p. 883-893
|
artikel
|
| 121 |
Possible Impact of Incremental Cost-Effectiveness Ratio (ICER) on Decision Making for Cancer Screening in Hong Kong: A Systematic Review
|
Wong, Carlos K. H.
|
|
2016
|
|
6 |
p. 647-657
|
artikel
|
| 122 |
Potential Impact of Sweetener Input Tax on Public Health
|
Lakkakula, Prithviraj
|
|
2018
|
|
6 |
p. 749-751
|
artikel
|
| 123 |
Preferences on Policy Options for Ensuring the Financial Sustainability of Health Care Services in the Future: Results of a Stakeholder Survey
|
Tordrup, David
|
|
2013
|
|
6 |
p. 639-652
|
artikel
|
| 124 |
Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices
|
Dane, Aniek
|
|
|
|
6 |
p. 905-914
|
artikel
|
| 125 |
Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe
|
Vončina, Luka
|
|
|
|
6 |
p. 915-927
|
artikel
|
| 126 |
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study
|
Cong, Ze
|
|
|
|
6 |
p. 845-856
|
artikel
|
| 127 |
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040
|
Ortega-Ortega, Marta
|
|
|
|
6 |
p. 877-889
|
artikel
|
| 128 |
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates
|
Espin, Jaime
|
|
2018
|
|
6 |
p. 803-817
|
artikel
|
| 129 |
Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection under Different Treatment Policies in Malaysia, 2018–2040
|
McDonald, Scott A.
|
|
2018
|
|
6 |
p. 847-857
|
artikel
|
| 130 |
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions
|
Raghunandan, Rakhee
|
|
|
|
6 |
p. 949-965
|
artikel
|
| 131 |
Reducing uncertainty in value-based pricing using evidence development agreements
|
Willis, Michael
|
|
2010
|
|
6 |
p. 377-386
|
artikel
|
| 132 |
Reforming the English NHS
|
Bloor, Karen
|
|
2010
|
|
6 |
p. 373-375
|
artikel
|
| 133 |
Review of Economic Submissions to NICE Medical Technologies Evaluation Programme
|
Alshreef, Abualbishr
|
|
2016
|
|
6 |
p. 623-634
|
artikel
|
| 134 |
Robustness and Effectiveness of the Triage System in the Pediatric Context
|
Montefiori, Marcello
|
|
2017
|
|
6 |
p. 795-803
|
artikel
|
| 135 |
SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance
|
Macmillan, Tom
|
|
2018
|
|
6 |
p. 779-791
|
artikel
|
| 136 |
Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment
|
Chugh, Yashika
|
|
|
|
6 |
p. 825-838
|
artikel
|
| 137 |
Systematic Review and Quality Assessment of Health Economic Evaluation Studies (2007–2019) Conducted in South Korea
|
Yi, Sunghyun
|
|
|
|
6 |
p. 819-834
|
artikel
|
| 138 |
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022
|
Meregaglia, Michela
|
|
|
|
6 |
p. 925-935
|
artikel
|
| 139 |
The Cost and Outcome Effectiveness of Total Hip Replacement: Technique Choice and Volume–Output Effects Matter
|
Goldstein, Jonathan P.
|
|
2016
|
|
6 |
p. 703-718
|
artikel
|
| 140 |
The Debrisoft® Monofilament Debridement Pad for Use in Acute or Chronic Wounds: A NICE Medical Technology Guidance
|
Meads, Catherine
|
|
2015
|
|
6 |
p. 583-594
|
artikel
|
| 141 |
The Economic Burden of Complications Occurring in Major Surgical Procedures: a Systematic Review
|
Patel, Ajay S.
|
|
2013
|
|
6 |
p. 577-592
|
artikel
|
| 142 |
The Health and Productivity Burden of Depression in South Korea
|
Zomer, Ella
|
|
|
|
6 |
p. 941-951
|
artikel
|
| 143 |
The Importance of Proximity to Death in Modelling Community Medication Expenditures for Older People: Evidence From New Zealand
|
Moore, Patrick V.
|
|
2014
|
|
6 |
p. 623-633
|
artikel
|
| 144 |
The MAGEC System for Spinal Lengthening in Children with Scoliosis: A NICE Medical Technology Guidance
|
Jenks, Michelle
|
|
2014
|
|
6 |
p. 587-599
|
artikel
|
| 145 |
The missing technology
|
Frogner, Bianca K.
|
|
2010
|
|
6 |
p. 361-371
|
artikel
|
| 146 |
The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review
|
Wright, Stuart J.
|
|
2015
|
|
6 |
p. 615-626
|
artikel
|
| 147 |
The Sandbox Approach and its Potential for Use in Health Technology Assessment: A Literature Review
|
Leckenby, Emily
|
|
|
|
6 |
p. 857-869
|
artikel
|
| 148 |
The use of research abstracts in formulary decision making by the joint oncology drug review of Canada
|
Weizman, Adam V.
|
|
2010
|
|
6 |
p. 387-391
|
artikel
|
| 149 |
The Value Employees Place on Health Insurance Plans: A Discrete-Choice Experiment
|
Poteet, Stephen
|
|
|
|
6 |
p. 817-825
|
artikel
|
| 150 |
Towards a New Understanding of Unmet Medical Need
|
Zhang, Kyann
|
|
|
|
6 |
p. 785-788
|
artikel
|
| 151 |
Towards Universal Health Coverage via Social Health Insurance in China: Systemic Fragmentation, Reform Imperatives, and Policy Alternatives
|
He, Alex Jingwei
|
|
2016
|
|
6 |
p. 707-716
|
artikel
|
| 152 |
Use of Expert Judgement Across NICE Guidance-Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation
|
Peel, Alison
|
|
2018
|
|
6 |
p. 819-836
|
artikel
|
| 153 |
Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
|
Bilger, Marcel
|
|
|
|
6 |
p. 841-855
|
artikel
|
| 154 |
Using Decision Trees to Manage Hospital Readmission Risk for Acute Myocardial Infarction, Heart Failure, and Pneumonia
|
Hilbert, John P.
|
|
2014
|
|
6 |
p. 573-585
|
artikel
|
| 155 |
What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population
|
Pauwels, Kim
|
|
|
|
6 |
p. 895-902
|
artikel
|
| 156 |
What Explains Willingness to Pay for Smoking-Cessation Treatments —Addiction Level, Quit-Rate Effectiveness or the Opening Bid?
|
Olsen, Jan Abel
|
|
2012
|
|
6 |
p. 407-415
|
artikel
|
| 157 |
What Explains Willingness to Pay for Smoking-Cessation Treatments —Addiction Level, Quit-Rate Effectiveness or the Opening Bid?
|
Olsen, Jan Abel
|
|
2012
|
|
6 |
p. 407-415
|
artikel
|
| 158 |
Willingness to Pay for Health Insurance Among HIV-Positive Patients in India
|
Gupta, Indrani
|
|
2014
|
|
6 |
p. 601-610
|
artikel
|
| 159 |
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China
|
Ye, Ziping
|
|
|
|
6 |
p. 893-904
|
artikel
|
| 160 |
Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran
|
Lankarani, Kamran Bagheri
|
|
2018
|
|
6 |
p. 837-846
|
artikel
|
Tijdschrift beschrijving